Sheldon L. Koenig - 17 May 2021 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Richard B. Bartram, by power of attorney
Issuer symbol
ESPR
Transactions as of
17 May 2021
Net transactions value
$0
Form type
4
Filing time
18 May 2021, 17:06:10 UTC
Next filing
01 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Award $0 +20,000 +67% $0.000000 50,000 17 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +120,000 $0.000000 120,000 17 May 2021 Common Stock 120,000 $20.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Such awards will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of June 15, 2021 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service
F2 Such options will vest over a four (4) year period as follows: 25% shall vest on the one year anniversary of June 15, 2021 and the remainder shall vest in equal quarterly installments over the three (3) year period thereafter, subject to continued service